A groundbreaking study has found that breastfeeding not only benefits infants but also offers mothers powerful immune protection against breast cancer, particularly the aggressive triple-negative type.
Researchers at the Peter MacCallum Cancer Centre in Melbourne discovered that breastfeeding triggers the activation of CD8⁺ T immune cells, which play a crucial role in defending the body against viruses and cancer cells.

Lead researcher Professor Sherene Loi explained that these immune cells remain within breast tissue for decades—up to 30 years after childbirth—providing long-term immunity and protection against cancer formation.

The study analyzed over 260 women’s breast tissue samples and found that those who had breastfed had significantly higher concentrations of these immune cells compared to those who had not.

In animal experiments, tumors grew much slower in mice that had experienced pregnancy and breastfeeding, supporting the theory that lactation induces long-term immune adaptations that reduce cancer risk.

Furthermore, women who had breastfed were more likely to recover from triple-negative breast cancer and showed stronger immune activity within tumor tissues.

According to the study, each additional year of breastfeeding lowers a woman’s lifetime risk of developing breast cancer by approximately 4%, making it a natural and effective way to enhance immune resilience and long-term protection.